最近在治疗儿科胆固醇性肝病方面的进展
Krupa R Mysore1, Katherine Cheng2, Lakshmi Anandini Suri3
1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Journal of pediatric gastroenterology and nutrition
|January 22, 2025
概括
儿科胆固醇性肝病需要优化管理,以提高生活质量和减缓疾病. 虽然状胆汁酸载体 (IBAT) 抑制剂对缓解症状有希望,但仍需要有效的疾病修饰疗法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 儿科胃肠病学 儿科胃肠病学
- 罕见疾病 罕见疾病
背景情况:
- 儿童胆固醇性肝病很少见,胆道缩,阿拉吉尔综合征 (ALGS) 和遗传胆酸运输障碍是常见的原因.
- 这些疾病会导致慢性或偶发性胆固醇衰竭,影响生活质量,由于缺乏治愈疗法,经常需要进行肝移植.
研究的目的:
- 为儿童胆固醇性肝病的营养,医疗和手术管理提供最新的审查.
- 评价最近的进展,包括使用大肠胆酸载体 (IBAT) 抑制剂,以管理这些疾病.
主要方法:
- 关于儿科胆固醇性肝病的当前文献和未来临床试验数据的综述.
- 对IBAT抑制剂等新兴疗法的疗效和局限性的分析.
主要成果:
- 临床试验表明,IBAT抑制剂可以改善ALGS和渐进性家族性肝内胆固醇症等疾病中的.
- 营养支持,医疗管理和手术干预对于改善患者的生活质量和减缓疾病进展至关重要.
结论:
- 优化管理对于儿科胆固醇性肝病至关重要,解决营养需求,毒性和生活质量.
- 尽管IBAT抑制剂在症状控制方面取得了进展,但开发能够阻止疾病进展的疗法仍然是儿科肝病管理中的关键未满足需求.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Diseases of the Liver and Gallbladder
420
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
420
Esophageal Varices-II: Clinical Features and Management
45
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
45
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93


